Sciclone Pharmaceuticals is a specialty pharmaceutical company focused on developing and marketing products to treat oncology, infectious diseases and urology.
In a step that is likely to unnerve global drugmakers, China has overhauled parts of its intellectual property law and mandated compulsory pharma licensing to allow its domestic pharmaceutical industry to make low-cost versions of medicines under patent protection
Written and published by Reuters.
Chugai Pharmaceutical manufactures, sells, imports and exports pharmaceuticals and has become the leading biopharmaceutical company in Japan.
This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in November 2014 and give you an exclusive opportunity to gain discounted annual subscription access to our database.
Nektar Therapeutics is a leading biopharma company developing clinical stage products based upon its advanced polymer conjugate chemistry technology.
Sorry, your search returned no results.
Samsung Medical Center and Pfizer Inc. announced that they have formed a research partnership to jointly analyze tumors from Korean patients to generate gene expression profiles and that may ultimately direct therapies and enhance clinical outcomes in the patients with liver cancer.
Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat, an investigational epigenetic therapy, with KEYTRUDA
Eli Lilly and Innovent Biologics announced one of the largest biotech drug development collaborations in China to date between a multi-national and domestic company
Molplex Pharmaceuticals has announced a pioneering new research collaboration agreement with AstraZeneca
Foundation Medicine and Roche enter into a broad strategic collaboration to further advance Foundation Medicine’s market-leading position in molecular information and genomic analysis